These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 4153252)
21. [Analysis of a therapeutic failure of L-Dopa: can Adams-Van Bosaert and Van Der Eecken's strio-nigral degeneration be diagnosed during the patient's life?]. André JM; Royer RJ; Duc M; Kissel P Rev Neurol (Paris); 1974; 130(7-8):322-6. PubMed ID: 4453761 [No Abstract] [Full Text] [Related]
22. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)]. Puca FM; Megna GF; Masi G; Specchio LM Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268 [No Abstract] [Full Text] [Related]
23. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease. Hauser RA; Olanow CW Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363 [TBL] [Abstract][Full Text] [Related]
24. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768 [TBL] [Abstract][Full Text] [Related]
27. L-Dopa therapy in Parkinson's disease. Greer M J Fla Med Assoc; 1970 Jun; 57(6):23-7. PubMed ID: 4392779 [No Abstract] [Full Text] [Related]
28. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor]. Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743 [No Abstract] [Full Text] [Related]
29. [Pallido-nigral degeneration--a case of Parkinson's syndrome resistant to L-dopa]. Matsuoka Y; Muroga T; Wakayama Y; Sugimura K; Matsui T Rinsho Shinkeigaku; 1977 Jan; 17(1):46-51. PubMed ID: 557400 [No Abstract] [Full Text] [Related]
30. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor]. Fischer PA; Schneider E; Jacobi P; Maxion H Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206 [No Abstract] [Full Text] [Related]
32. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor]. Christiani K; Möller WD Munch Med Wochenschr; 1973 Apr; 115(16):711-3. PubMed ID: 4197759 [No Abstract] [Full Text] [Related]